Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Sugammadex × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 2 Urologic Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Obesity 1 Neuromuscular Blockade 1 Myasthenia Gravis 1 Endobronchial Metastases 1 Delayed Emergence from Anesthesia 1 Brain Neoplasms 1

Interventions

Docetaxel 147 Prednisone 113 Leuprolide 83 enzalutamide 74 Radiotherapy 71 bicalutamide 68 Abiraterone Acetate 68 Goserelin 66 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 49 Zoledronic Acid 37 Magnetic Resonance Spectroscopy 35 Estramustine 30 gallium 68 PSMA-11 28 abiraterone 27 Flutamide 27 apalutamide 26 radium Ra 223 dichloride 24 Radiosurgery 22 Gonadotropin-Releasing Hormone 21 Androgen Antagonists 21 cabazitaxel 20 Surveys and Questionnaires 20 Dutasteride 20 sipuleucel-T 19 Paclitaxel 19 Radiation 18 Exercise 18 Prednisolone 17 Mitoxantrone 17 Brachytherapy 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04854993 2023-01-25

RECIR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡